SCHEMBL2269088

SCHEMBL2269088

O=C(O)c1ccc(Oc2ccccc2)cc1NS(=O)(=O)/C=C/c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.58
CYP2C19 P33261 1/20 0.58
ALDH1A1 P00352 3/20 0.56
KMT2A Q03164 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
POLB P06746 1/20 0.56
GAA P10253 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
PPARG P37231 3/20 0.52
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
CYP1A2 P05177 1/20 0.46
PTGES2 Q9H7Z7 2/20 0.46
MCL1 Q07820 2/20 0.46
SCN9A Q15858 1/20 0.45
NFE2L2 Q16236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2269092 1.00 CYP2C9 (0.58) CYP2C9CYP2C19ALDH1A1KMT2AKDM4E
SCHEMBL2276179 0.86 CYP2C9 (0.46) CYP2C9CYP2C19ALDH1A1KMT2AKDM4E
SCHEMBL2276172 0.86 CYP2C9 (0.46) CYP2C9CYP2C19ALDH1A1KMT2AKDM4E
SCHEMBL27716659 0.83 KMT2A (0.62) ALDH1A1KMT2AKDM4EMEN1POLB
SCHEMBL2275487 0.81 ACLY (0.61) ALDH1A1KMT2AKDM4EMEN1POLB
SCHEMBL2275485 0.81 ACLY (0.61) ALDH1A1KMT2AKDM4EMEN1POLB
SCHEMBL13561005 0.80 KMT2A (0.60) ALDH1A1KMT2AKDM4EMEN1POLB
SCHEMBL2275112 0.78 CYP2C9 (0.83) CYP2C9CYP2C19CYP1A2MCL1
SCHEMBL2271008 0.78 KMT2A (0.56) ALDH1A1KMT2AKDM4EMEN1POLB
SCHEMBL5147679 0.78 KMT2A (0.56) ALDH1A1KMT2AKDM4EMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094829-B novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO.,LTD. (JP) 2012-02-08 CN disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 CYP2C9 841/4885CYP2C19 1098/4885ALDH1A1 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.